加巴喷丁对患有和未患有慢性肾病的猫的血压影响评估

乐活   2024-09-10 22:00   重庆  

加巴喷丁对患有和未患有慢性肾病的猫的血压影响评估


期号Vol 26, Issue 4, May 8, 2024
作者:Jessica M Quimby Sarah E Jones

摘要来源:https://journals.sagepub.com/doi/full/10.1177/1098612X241240326

://journals.sagepub.com/doi/full/10.1177/1098612X241241408

译员:深蓝猫猫侠

一校:郭嘉恩

二校:kenda


摘要



目标

       

本研究的目的是评估加巴喷丁对患有和未患有慢性肾病(CKD)猫的血压(BP)影响。

方法

       

 进行了一项随机、盲法、安慰剂对照的交叉研究。共纳入29只猫:13只患有稳定CKD的猫(IRIS阶段2-4)和16只健康猫(血清肌酐<1.6mg/dl且尿比重>1.035)。对每只猫进行了两次评估,间隔约1周。猫在服用单次剂量的加巴喷丁(10mg/kg,口服)或安慰剂后3小时进行了血压测量(使用多普勒血压计)。每只猫在每次就诊时都使用相同的多普勒设备和血压计单元,由同一猫保定者和多普勒操作员在相同位置进行血压测量。

结果

与服用安慰剂后的血压(中位数150mmHg,范围102191P=0.001)相比,服用单次剂量的加巴喷丁(10mg/kg,口服)后,猫的血压显著降低(中位数122mmHg,范围82170。在慢性肾病(CKD)亚组中,与服用安慰剂后的血压(中位数155mmHg,范围102191P=0.008)相比,服用加巴喷丁后的血压显著降低(中位数129mmHg,范围96170。在健康猫亚组中,与服用安慰剂后的血压(中位数137mmHg,范围102177P=0.002)相比,服用加巴喷丁后的血压显著降低(中位数121mmHg,范围82139。健康猫的血压中位变化为−12mmHg(范围−9510),CKD猫的血压中位变化为−12mmHg(范围−4321)(两亚组之间无显著差异)。


结论和相关性


加巴喷丁可能会降低患有和未患有慢性肾病的猫的动脉血压,在需要测量血压的患者中使用加巴喷丁时应考虑到这一



原文:

Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease

Jessica M Quimby Sarah E Jones
https://journals.sagepub.com/doi/full/10.1177/1098612X241240326

Abstract

Objectives

The aim of the present study was to assess the effect of gabapentin on blood pressure (BP) in cats with and without chronic kidney disease (CKD).

Methods

A randomized, blinded, placebo-controlled crossover study was performed. A total of 29 cats were included: 13 cats with stable CKD (IRIS stage 2–4) and 16 apparently healthy cats (serum creatinine <1.6 mg/dl and urine specific gravity >1.035). The cats were evaluated twice, approximately 1 week apart, and BP (Doppler sphygmomanometry) was obtained 3 h after cats received either a single dose of gabapentin 10mg/kg PO or placebo. For each cat, BP readings were obtained at each visit using the same Doppler and sphygmomanometer unit, and the same cat holder and Doppler operator, in the same location.

Results

After administration of a single dose of gabapentin (10 mg/kg PO), BP was significantly lower (median 122 mmHg, range 82–170) than after administration of the placebo (median 150 mmHg, range 102–191; P = 0.001). In the CKD subgroup, BP was significantly lower after administration of gabapentin (median 129 mmHg, range 96–170) than after administration of the placebo (median 155 mmHg, range 102–191; P = 0.008). In the healthy cat subgroup, BP was significantly lower after administration of gabapentin (median 121 mmHg, range 82–139) than after administration of the placebo (median 137 mmHg, range 102–177; P = 0.002). The median change in BP was −12 mmHg (range −95 to 10) for healthy cats and −12 mmHg (range −43 to 21) for cats with CKD (no significant difference between subgroups).

Conclusions and relevance

Gabapentin may decrease arterial BP in cats with and without CKD and these findings should be taken into account when gabapentin is administered to patients in which measurement of BP is needed.

深蓝猫科
我们,为猫代言!We speak for cats!
 最新文章